Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-16 Purchase | 2024-09-17 8:05 pm | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
| 2024-08-13 Sale | 2024-08-15 5:06 pm | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) | View |
| 2024-07-15 Sale | 2024-07-17 8:53 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 56,164 | $10 | $561,640 | 755,635 (Indirect) | View |
| 2024-05-15 Sale | 2024-05-20 4:39 pm | BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner | 24,344 | $0.3812 | $9,280 | 13,773,653 (Indirect) | View |
| 2024-01-30 Purchase | 2024-01-31 4:11 pm | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) | View |
| 2024-01-25 Purchase | 2024-01-26 7:13 pm | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 3,125,000 | $2.4 | $7,500,000 | 2,930,527 (Indirect) | View |
| 2023-07-17 Purchase | 2023-07-19 4:17 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) | View |
| 2023-06-27 Purchase | 2023-06-29 4:51 pm | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 875,000 | $2.09 | $1,828,750 | 962,339 (Indirect) | View |
| 2023-05-04 Purchase | 2023-05-08 5:11 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) | View |
| 2023-04-28 Purchase | 2023-05-02 9:38 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) | View |
| 2023-02-27 Purchase | 2023-03-17 4:29 pm | BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner | 348,000 | $0.245 | $85,260 | 4,951,448 (Indirect) | View |
| 2022-12-23 Purchase | 2022-12-28 5:46 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 137,931 | $7.25 | $1,000,000 | 7,619,135 (Indirect) | View |
| 2022-11-08 Purchase | 2022-11-10 4:38 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) | View |
| 2022-11-07 Purchase | 2022-11-09 4:29 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) | View |
| 2022-08-16 Purchase | 2022-08-18 4:50 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 3,690,000 | $2.42 | $8,929,800 | 1,072,400 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Conversion | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-09-16 Conversion | 2024-09-17 8:05 pm | N/A N/A | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
| 2024-09-12 Option Award | 2024-09-13 5:19 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 15,963 | $0 | 15,963 (Direct) | View |
Ownership | 2024-09-12 7:15 pm | N/A N/A | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 0 | $0 | 3,062,215 (Indirect) | View |
| 2024-08-21 Disposition | 2024-08-23 4:08 pm | N/A 2030-09-16 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 93,400 | $0 | 93,400 (Direct) | View |
| 2024-08-21 Option Award | 2024-08-23 4:08 pm | N/A 2030-09-16 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 93,400 | $0 | 93,400 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-02 6:36 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 4,676 | $0 | 4,676 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-14 6:04 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:08 pm | N/A 2034-06-04 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 32,300 | $0 | 11,485,340 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-20 4:39 pm | 2023-05-04 2033-05-04 | BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner | 9,280,408 | $0 | 13,773,653 (Indirect) | View |
| 2024-05-15 Exercise | 2024-05-20 4:39 pm | N/A N/A | BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner | 9,280,408 | $0.244 | 13,773,653 (Indirect) | View |
| 2024-04-03 Disposition | 2024-04-05 4:39 pm | N/A 2030-12-02 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 8,095,480 | $0 | 0 (Direct) | View |
| 2024-02-14 Disposition | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 3,250 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
| 2024-02-09 Option Award | 2024-02-14 12:02 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-01-30 Conversion | 2024-01-31 4:11 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 2,582,884 | $0 | 1,513,664 (Indirect) | View |
Ownership | 2024-01-25 8:36 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 0 | $0 | 2,582,884 (Indirect) | View |
| 2023-08-14 Disposition | 2023-08-16 6:08 pm | N/A 2030-09-16 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 93,400 | $0 | 93,400 (Direct) | View |
| 2023-08-14 Option Award | 2023-08-16 6:08 pm | N/A 2030-09-16 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 93,400 | $0 | 93,400 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:29 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:29 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:48 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 5:47 pm | N/A 2033-05-31 | Adicet Bio Inc. | ACET | GORDON CARL L Director | 32,300 | $0 | 32,300 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 4:30 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 550,000 | $0 | 4,593,629 (Indirect) | View |
| 2023-02-08 Option Award | 2023-02-09 4:28 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 5:00 pm | N/A 2032-06-13 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director | 20,250 | $0 | 20,250 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 8:10 pm | N/A 2032-06-09 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |